Bristol-Myers Squibb (BMY) 424B5 Prospectus supplement for primary offering

Exhibit 107

Calculation of Filing Fee Tables

424(b)(5)

(Form Type)

Bristol-Myers Squibb Company

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price(1)(8)

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial effective date

Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Fees to Be Paid

Debt

2.950% Notes due 2032

457(r)

$1,750,000,000

99.637%

$1,743,647,500

0.0000927

$161,636.12

Fees to Be Paid

Debt

3.550% Notes due 2042

457(r)

$1,250,000,000

99.658%

$1,245,725,000

0.0000927

$115,478.71

Fees Previously Paid

Debt

3.700% Notes due 2052

457(r)

$2,000,000,000

99.567%

$1,991,340,000

0.0000927

$184,597.22

Fees to Be Paid

Debt

3.900% Notes due 2062

457(r)

$1,000,000,000

99.516%

$995,160,000

0.0000927

$92,251.33

Carry Forward Securities

Carry Forward Securities

Total Offering Amounts

$5,975,872,500

$553,963.38

Total Fees Previously Paid

Total Fee Offsets

Net Fee Due

$553,963.38